L.p. Fund Impact Oncology Ubs
Affiliations
- Other at Iteos Therapeutics Inc. (ITOS), 2025-05-15
- Large Shareholder at Werewolf Therapeutics Inc. (HOWL), 2025-04-30
- Large Shareholder at Tcr2 Therapeutics Inc. (TCRR), 2023-06-05
- Large Shareholder at Cullinan Oncology Inc. (CGEM), 2021-09-20
- Large Shareholder at Harpoon Therapeutics Inc. (HARP), 2021-06-02
- Large Shareholder at Oncorus Inc. (ONCR), 2020-10-08
- Large Shareholder at Spring Bank Pharmaceuticals Inc. (SBPH), 2018-02-06
- Large Shareholder at Sunesis Pharmaceuticals Inc (SNSS), 2017-11-07
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| CGEM | $21.00 | 300,000 | $6,300,000.00 | 7,913,887 | 2021-01-12 | Filing |
| ONCR | $15.00 | 151,224 | $2,268,360.00 | 2,377,025 | 2020-10-06 | Filing |
| TCRR | $15.00 | 666,667 | $10,000,005.00 | 3,370,982 | 2019-02-19 | Filing |
| HARP | $14.00 | 250,000 | $3,500,000.00 | 3,898,422 | 2019-02-12 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| CGEM | $29.06 | 3,124 | $90,783.44 | 7,648,268 | 2021-09-16 | Filing |
| CGEM | $29.16 | 6,425 | $187,353.00 | 7,651,392 | 2021-09-15 | Filing |
| CGEM | $29.17 | 7,106 | $207,282.02 | 7,657,817 | 2021-09-14 | Filing |
| CGEM | $29.10 | 3,595 | $104,614.50 | 7,664,923 | 2021-09-13 | Filing |
| CGEM | $29.04 | 5,931 | $172,236.24 | 7,668,518 | 2021-09-10 | Filing |